NRC Health (NRC): Capital Expenditures
$10.71M
Year ended 2025-12-31
$7.87M
Trailing 12 months to 2026-06-30
+2.9%
3-year compound annual growth
+21.9%
5-year compound annual growth
+13.8%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.71M | -30.7% | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | $15.45M | -2.1% | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | $15.78M | +60.4% | 2026-03-05, From 2023-01-01 |
| 2022-12-31 | $9.84M | +78.4% | 2025-03-17, From 2022-01-01 |
| 2021-12-31 | $5.51M | +38.4% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $3.98M | -14.4% | 2023-03-03, From 2020-01-01 |
| 2019-12-31 | $4.66M | -22.0% | 2022-03-04, From 2019-01-01 |
| 2018-12-31 | $5.97M | +30.7% | 2021-03-05, From 2018-01-01 |
| 2017-12-31 | $4.57M | +15.0% | 2020-03-06, From 2017-01-01 |
| 2016-12-31 | $3.97M | +35.2% | 2019-03-08, From 2016-01-01 |
| 2015-12-31 | $2.94M | +17.9% | 2018-03-14, From 2015-01-01 |
| 2014-12-31 | $2.49M | +13.9% | 2017-03-03, From 2014-01-01 |
| 2013-12-31 | $2.19M | -6.8% | 2016-03-04, From 2013-01-01 |
| 2012-12-31 | $2.35M | -16.5% | 2015-03-04, From 2012-01-01 |
| 2011-12-31 | $2.81M | +82.7% | 2014-03-04, From 2011-01-01 |
| 2010-12-31 | $1.54M | -47.1% | 2013-03-01, From 2010-01-01 |
| 2009-12-31 | $2.91M | n/a | 2012-03-01, From 2009-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| NRC Health (NRC) | 2025-12-31 | $10.71M | -30.7% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $1.77M | +7.1% |
| OmniAb, Inc. (OABI) | 2025-12-31 | $565.0K | -69.9% |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | $62.0K | n/a |
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $31.36M | -14.2% |
| bioAffinity Technologies, Inc. (BIAF) | 2025-12-31 | $60.6K | -23.4% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $219.15M | -5.9% |
| Absci Corp (ABSI) | 2025-12-31 | $1.11M | +174.0% |
| Icon PLC (ICLR) | 2025-12-31 | $174.21M | +3.7% |
Compare NRC, MXCT, OABI, FOXO side by side · Screen every company in Services-Commercial Physical & Biological Research ↗